We use diffuse optical breast tomography during fractional mammographic compression to monitor neoadjuvant chemotherapy response. Preliminary results show static and dynamic measurements are sensitive to therapy induced changes in breast cancer.

© 2012 Optical Society of America

PDF Article
More Like This
Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Using Dynamic Tomographic Optical Breast imaging (DTOBI)

Amir Y. Sajjadi, Steven J. Isakoff, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Stefan A. Carp
BW4B.5 Biomedical Optics (BIOMED) 2014

Diffuse Optical Tomography Imaging System for Monitoring Breast Tumor Response to Neoadjuvant Chemotherapy

Jacqueline Gunther, Molly Flexman, Emerson Lim, Hyun Keol Kim, Mindy Brown, Dawn Hershman, and Andreas H. Hielscher
BW3A.6 Biomedical Optics (BIOMED) 2012

Computer Aided Monitoring of Neoadjuvant Chemotherapy for Breast Cancer

David R. Busch, Wensheng Guo, Regine Choe, Turgut Durduran, Michael D. Feldman, Carolyn Mies, Brian J. Czerniecki, Julia Tchou, Angela DeMichele, Mark A. Rosen, Michael D. Schnall, and Arjun G. Yodh
BSu5A.7 Biomedical Optics (BIOMED) 2012


You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an Optica member, or as an authorized user of your institution.

Contact your librarian or system administrator
Login to access Optica Member Subscription